WuXi PharmaTech (Cayman) Inc. Interest Expense
WuXi PharmaTech (Cayman) Inc. reported Interest Expense of $2.58 million for the 12-month period ending 2014-12-31, per its 20-F filed 2015-04-15.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2015-04-15
| Period end | Interest Expense 12 month |
|---|---|
| 2014-12-31 | $2.58M 20-F · filed 2015-04-15 |
| 2013-12-31 | $1.95M 20-F · filed 2015-04-15 |
| 2012-12-31 | $1.72M 20-F · filed 2015-04-15 |
| 2011-12-31 | $790.00K 20-F · filed 2014-04-15 |
| 2010-12-31 | $436.00K 20-F · filed 2013-04-17 |
| 2009-12-31 | $1.07M 20-F · filed 2012-04-20 |
| 2008-12-31 | $1.39M 20-F · filed 2011-04-27 |